Trial reportInternational journal of surgery (London, England)2026
Three-dimensionally printed navigational template technology for lung biopsy: a noninferiority, randomized trial.
Trial report in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPercutaneous transthoracic needle biopsy (PTNB) guided by computed tomography (CT) greatly depends on the operators' skill for accuracy. This study aimed to evaluate whether three-dimensionally (3D)-printed navigational templates for PTNB achieve diagnostic yield comparable to conventional CT guidance. MATERIALS AND
methodsConducted from 1 November 2020 to 27 July 2023, this noninferiority randomized clinical trial included 159 patients with peripheral lung masses (≥30 mm). The analyses were performed using intention-to-treat (ITT) and per-protocol approaches.
resultsA total of 150 patients were enrolled, with 144 analyzed in ITT analysis (72 per group). Diagnostic yields were 91.7% in the template-guided group and 94.4% in the CT-guided group, confirming noninferiority (difference, -2.8%; 95% CI, -11.1%-5.5%). There was no significant difference in biopsy deviation between the two groups (9.6 [4.6] mm vs 10.1 [3.4] mm; P = 0.505). The template-guided group exhibited shorter procedural duration (10.2 vs. 12.8 minutes; P < 0.001) and reduced radiation exposure (dose-length product: 233.4 vs. 320.1 mGy × cm; P < 0.001). Complication rates, including pneumothorax and hemorrhage, did not significantly differ between groups.
conclusions3D-printed navigational templates for lung biopsy demonstrated noninferior diagnostic efficacy compared to CT guidance, significantly reducing procedure duration and radiation exposure. This technology enhances biopsy efficiency, benefiting operators with limited experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.